Share chart GlaxoSmithKline
Extended chart
Simple chart
About GlaxoSmithKline
GlaxoSmithKline plc вместе со своими дочерними компаниями занимается созданием, открытием, разработкой, производством и маркетингом фармацевтических продуктов, вакцин, безрецептурных лекарств и потребительских товаров для здоровья в Великобритании, США и на международном уровне. Он работает в четырех сегментах: фармацевтика, исследования и разработки в фармацевтике, вакцины и здравоохранение. more details| IPO date | 1986-07-09 |
|---|---|
| ISIN | US37733W2044 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | gbp |
| Див.доход ао | 4.48 |
| Дивиденд ао | 0.401 |
| Сайт | https://www.gsk.com |
| Цена ао | 38.58 |
| Change price per day: | +3.1% (33.6) |
|---|---|
| Change price per week: | -5.17% (36.53) |
| Change price per month: | -10.91% (38.88) |
| Change price per 3 month: | +4.68% (33.09) |
| Change price per half year: | -11.47% (39.13) |
| Change price per year: | -14.47% (40.5) |
| Change price per 3 year: | -17.9% (42.19) |
| Change price per 5 year: | -7.06% (37.27) |
| Change price per 10 year: | +4.35% (33.195) |
| Change price per year to date: | +3.1% (33.6) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Dodge & Cox Inc | 69026793 | 3.33 |
| FMR, LLC | 19366131 | 0.93 |
| Fisher Asset Management, LLC | 15036881 | 0.73 |
| Price (T.Rowe) Associates Inc | 12818958 | 0.62 |
| JTC Employer Solutions Trusteee Ltd | 12340190 | 0.6 |
| PRIMECAP Management Company | 12089370 | 0.58 |
| Morgan Stanley | 8552173 | 0.41 |
| Royal Bank of Canada | 8286487 | 0.4 |
| Holocene Advisors, LP | 8224548 | 0.4 |
| State Street Corporation | 7052990 | 0.34 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| SPDR Solactive United Kingdom ETF | 3.6 | 50.67 | 3.94 |
| Pacer BioThreat Strategy ETF | 2.84213 | 13.38 | 1.65371 |
| Barclays ETN+ FI Enhanced Europe 50 ETN Series C | 2.37 | 0 | 1.05 |
| AAM S&P Developed Markets High Dividend Value ETF | 1.88686 | 11.63 | 7.65946 |
| VanEck Morningstar Global Wide Moat ETF | 1.78619 | 58.27 | 2.44324 |
| Pacific Global International Equity Income ETF | 1.72 | 0 | 2.68 |
| FCF International Quality ETF | 1.64717 | 1.11 | 2.88048 |
| Nuveen Global Net Zero Transition ETF | 1.28105 | 16.12 | 1.77096 |
| Knowledge Leaders Developed World ETF | 1.24702 | 14.17 | 1.90235 |
| Credit Suisse FI Enhanced Europe 50 ETN | 0.93 | 49.45 | |
| FlexShares International Quality Dividend Defensive Index Fund | 0.7774 | 13.37 | 5.72758 |
| E-TRACS UBS Bloomberg CMCI Food ETN | 0.49648 | 17.97 | 2.94932 |
| Fidelity New Millennium ETF | 0.33039 | -5.13 | 1.58241 |
| IQ 500 International ETF | 0.32773 | 6.72 | 4.03885 |
| VictoryShares Developed Enhanced Volatility Wtd ETF | 0.23444 | 11.06 | 3.73508 |
| 1.43 | 17.25 | 2.93 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Sarah Elton-Farr | Head of Investor Relations | N/A | |
| Mr. James Ford | Senior VP & Group General Counsel of Legal & Compliance | N/A | |
| Ms. Sally Jackson | Senior Vice President of Global Communications & CEO Office | N/A | |
| Ms. Diana Conrad | Chief People Officer | N/A | |
| Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer | N/A | 1971 (54 years) |
| Ms. Emma Natasha Walmsley | CEO & Director | 6.82M | 1969 (56 years) |
| Mr. Tony Wood | Chief Scientific Officer and Head of R&D | N/A | |
| Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development | N/A | 1966 (59 years) |
| Mr. Philip C. Thomson | President of Global Affairs | N/A | |
| Ms. Julie Belita Brown | CFO & Executive Director | 6.51M | 1962 (63 years) |
Address: United Kingdom, Brentford, 980 Great West Road - open in Google maps, open in Yandex maps
Website: https://www.gsk.com
Website: https://www.gsk.com
